Support our Foundation of Myology project
1710 news items
A more accurate method for screening for asymptomatic carriers of SMA in the general population
On 05/11/2026
Chinese researchers have developed a new technique for screening for heterozygotes for infantile spinal muscular atrophy (SMA):
Certain forms of myasthenia gravis carry a higher risk of pneumonia during the Covid-19 pandemic
On 04/11/2026
As part of an international, multicentre observational study focusing on respiratory complications, clinicians analysed the outcomes of patients with myasthenia gravis during the COVID-19 pandemic:…
Pan-German guidelines on the adverse effects of gene therapy in SMA
On 04/11/2026
Clinicians from Germany, Austria and German-speaking Switzerland involved in the treatment of SMN1-related proximal spinal muscular atrophy (SMA) have drawn up recommendations concerning the follow-up…
An update on iatrogenic adrenal insufficiency in DMD
On 04/11/2026
A North American consortium of clinicians has examined one of the rare but potentially extremely serious complications of long-term corticosteroid use in Duchenne muscular dystrophy…
An Italian study on anaesthetic practice in Charcot-Marie-Tooth disease
On 03/11/2026
The Italian consortium dedicated to Charcot-Marie-Tooth disease (CMT) has carried out a survey on the procedures, patient experiences and outcomes of anaesthesia administered to patients…
A review of the medical literature on cases of seronegative myasthenia gravis
On 03/11/2026
Clinicians from Florence (Italy) have conducted a comprehensive analysis of the literature on so-called ‘seronegative’ myasthenia gravis, which is a relatively common presentation in clinical…
A new ultrasound-guided technique for complex lumbar punctures
On 02/11/2026
Chinese anaesthetists report on their experience of performing complex lumbar punctures in two adults with spinal muscular atrophy being treated with nusinersen: This protocol still…
An innovative technique for assessing the impact of antisense oligonucleotides on the central nervous system
On 02/11/2026
French and Dutch researchers sought to identify the effects of antisense oligonucleotides (ASOs) on the central nervous system (CNS) in Duchenne muscular dystrophy (DMD): This…
Assessing falls in Charcot-Marie-Tooth disease
On 02/11/2026
Researchers in Clermont-Ferrand investigated the risk of falls in hereditary sensory and motor neuropathy of the CMT-1A type (associated with a duplication of the PMP22…
Proteomics studies to gain a better understanding of titinopathies
On 30/10/2026
The French consortium dedicated to research into neuromuscular disorders linked to the TTN gene, which encodes titin, reports on its work in the field of…
Efgartigimod is more rapidly effective than intravenous immunoglobulins in myasthenia gravis
On 23/10/2026
Chinese clinicians compared two immunotherapies for generalised forms of autoimmune myasthenia gravis: To achieve a faster therapeutic response, the authors recommend the use of efgartigimod.
Identification of a new mechanism underlying muscle pathology in DM1
On 19/10/2026
Researchers from the Repeat Expansions & Myotonic Dystrophy (REDs) team in the Center of Research in Myology at the Institute, whose work focuses on type…
ALS: the thymus is both a target and a factor in the maintenance of the pathological process
On 16/10/2026
Julia Pereira Lemos, a researcher in the Biotherapy for motor neuron diseases (ALS & SMA) team in the Center for Research in Myology at the…
CAR-T cells have led to a remission lasting at least 19 months in three patients with myasthenia gravis
On 14/10/2026
The anti-CD19 CAR-T cells KYV-101 are being evaluated in a Phase II/III trial involving 66 patients with refractory generalised autoimmune myasthenia gravis. Initial results for…
A look back at the 2026 edition of the Fête de la Science at the Institute
On 13/10/2026
To mark the Fête de la Science, the Institute opened its doors for two days, on Wednesday 7 and Friday 9 October, to showcase its…
Registration is now open for the AcadeMYO Winter School – 14-16 Dec. 2026 – online
On 12/10/2026
Join us for this unique opportunity to perfect your skills in myology, an increasingly exciting discipline dedicated to neuromuscular science!All professionals manifesting some interest in…
SMA: a new treatment targeting muscle has just been approved for marketing in the US
On 12/10/2026
Isembyld (apitegromab) has been granted US marketing authorisation for the treatment of SMA On 11 September 2026, the US Food and Drug Administration (FDA) granted…
The Institut de Myologie’s open-pace race, MyoRun, is celebrating its 20th edition!
On 09/10/2026
This year, the MyoRun open-pace race is celebrating its 20th edition and is offering two sporting and charitable events in aid of the 2026 Telethon!…
The diagnostic and pathophysiological challenges of toxic vacuolar myopathies
On 09/10/2026
Clinician and researchers from the Institute of Myology, in collaboration with international researchers, have investigated myopathies induced by chloroquine (and its derivatives, referred to by…
Muscle biopsy: a diagnostic technique that remains useful despite advances in genetics
On 08/10/2026
Italian researchers have examined the diagnostic value of muscle biopsy at a time when high-throughput sequencing (NGS) and immunoassays are increasingly relegating it to a…
